Drug name - Levothyroxine Sodium

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9168239 FRESENIUS KABI USA Levothyroxine formulations Aug, 2032

(9 years from now)

US9168238 FRESENIUS KABI USA Levothyroxine formulations Aug, 2032

(9 years from now)

US9006289 FRESENIUS KABI USA Levothyroxine formulations Oct, 2032

(10 years from now)

US11135190 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

US9782376 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

US10398669 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
100MCG/VIAL POWDER;INTRAVENOUS Prescription
200MCG/VIAL POWDER;INTRAVENOUS Prescription
500MCG/VIAL POWDER;INTRAVENOUS Prescription
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11154498 CUSTOPHARM INC Stabilized liquid formulation of levothyroxine Jul, 2036

(13 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
100MCG/ML SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.